Pharmacokinetics, optimal dosages and withdrawal time of amoxicillin in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C
Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C as well as to determine optimal dosages...
Saved in:
Published in | The Veterinary quarterly Vol. 44; no. 1; pp. 1 - 9 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
01.12.2024
Taylor & Francis Ltd Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C as well as to determine optimal dosages and drug withdrawal time (WDT). In the PK investigation, the fish received a single dose of 40 mg/kg AMX via oral gavage, and the optimal dosage was determined by the pharmacokinetic-pharmacodynamic approach. In the tissue residue study, the fish were orally gavaged with 40 mg/kg/day AMX once daily for 5 days and the WDT was established by the linear regression analysis. The results revealed the temperature-dependent drug elimination; the clearance relative to bioavailability (CL/F) and elimination half-life at 30 °C (0.180 L/kg/h and 6.06 h, respectively) were about twice those at 25 °C (0.090 L/kg/h and 10.49 h, respectively). The optimal dosages at the minimum inhibitory concentration (MIC) of 2 μg/mL were 10.97 (25 °C) and 41.03 (30 °C) mg/kg/day, respectively. Finally, following the multiple oral administration, the muscle/skin residue of AMX on day 1 after the last dosing at 25 and 30 °C were 548 and 264 ng/g, respectively. The average tissue residues were depleted below the maximum residue limits (MRL) of 50 μg/kg on day 5 (25 °C) and 3 (30 °C), respectively, and the WDT were 6 and 4 days when rearing at 25 and 30 °C, respectively. This knowledge serves as a practical guideline for responsible use of AMX in treating bacterial diseases in Nile tilapia aquaculture. |
---|---|
AbstractList | Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia (
) reared at 25 and 30 °C as well as to determine optimal dosages and drug withdrawal time (WDT). In the PK investigation, the fish received a single dose of 40 mg/kg AMX
oral gavage, and the optimal dosage was determined by the pharmacokinetic-pharmacodynamic approach. In the tissue residue study, the fish were orally gavaged with 40 mg/kg/day AMX once daily for 5 days and the WDT was established by the linear regression analysis. The results revealed the temperature-dependent drug elimination; the clearance relative to bioavailability (CL/F) and elimination half-life at 30 °C (0.180 L/kg/h and 6.06 h, respectively) were about twice those at 25 °C (0.090 L/kg/h and 10.49 h, respectively). The optimal dosages at the minimum inhibitory concentration (MIC) of 2 μg/mL were 10.97 (25 °C) and 41.03 (30 °C) mg/kg/day, respectively. Finally, following the multiple oral administration, the muscle/skin residue of AMX on day 1 after the last dosing at 25 and 30 °C were 548 and 264 ng/g, respectively. The average tissue residues were depleted below the maximum residue limits (MRL) of 50 μg/kg on day 5 (25 °C) and 3 (30 °C), respectively, and the WDT were 6 and 4 days when rearing at 25 and 30 °C, respectively. This knowledge serves as a practical guideline for responsible use of AMX in treating bacterial diseases in Nile tilapia aquaculture. Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C as well as to determine optimal dosages and drug withdrawal time (WDT). In the PK investigation, the fish received a single dose of 40 mg/kg AMX via oral gavage, and the optimal dosage was determined by the pharmacokinetic-pharmacodynamic approach. In the tissue residue study, the fish were orally gavaged with 40 mg/kg/day AMX once daily for 5 days and the WDT was established by the linear regression analysis. The results revealed the temperature-dependent drug elimination; the clearance relative to bioavailability (CL/F) and elimination half-life at 30 °C (0.180 L/kg/h and 6.06 h, respectively) were about twice those at 25 °C (0.090 L/kg/h and 10.49 h, respectively). The optimal dosages at the minimum inhibitory concentration (MIC) of 2 μg/mL were 10.97 (25 °C) and 41.03 (30 °C) mg/kg/day, respectively. Finally, following the multiple oral administration, the muscle/skin residue of AMX on day 1 after the last dosing at 25 and 30 °C were 548 and 264 ng/g, respectively. The average tissue residues were depleted below the maximum residue limits (MRL) of 50 μg/kg on day 5 (25 °C) and 3 (30 °C), respectively, and the WDT were 6 and 4 days when rearing at 25 and 30 °C, respectively. This knowledge serves as a practical guideline for responsible use of AMX in treating bacterial diseases in Nile tilapia aquaculture. Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C as well as to determine optimal dosages and drug withdrawal time (WDT). In the PK investigation, the fish received a single dose of 40 mg/kg AMX via oral gavage, and the optimal dosage was determined by the pharmacokinetic-pharmacodynamic approach. In the tissue residue study, the fish were orally gavaged with 40 mg/kg/day AMX once daily for 5 days and the WDT was established by the linear regression analysis. The results revealed the temperature-dependent drug elimination; the clearance relative to bioavailability (CL/F) and elimination half-life at 30 °C (0.180 L/kg/h and 6.06 h, respectively) were about twice those at 25 °C (0.090 L/kg/h and 10.49 h, respectively). The optimal dosages at the minimum inhibitory concentration (MIC) of 2 μg/mL were 10.97 (25 °C) and 41.03 (30 °C) mg/kg/day, respectively. Finally, following the multiple oral administration, the muscle/skin residue of AMX on day 1 after the last dosing at 25 and 30 °C were 548 and 264 ng/g, respectively. The average tissue residues were depleted below the maximum residue limits (MRL) of 50 μg/kg on day 5 (25 °C) and 3 (30 °C), respectively, and the WDT were 6 and 4 days when rearing at 25 and 30 °C, respectively. This knowledge serves as a practical guideline for responsible use of AMX in treating bacterial diseases in Nile tilapia aquaculture.Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C as well as to determine optimal dosages and drug withdrawal time (WDT). In the PK investigation, the fish received a single dose of 40 mg/kg AMX via oral gavage, and the optimal dosage was determined by the pharmacokinetic-pharmacodynamic approach. In the tissue residue study, the fish were orally gavaged with 40 mg/kg/day AMX once daily for 5 days and the WDT was established by the linear regression analysis. The results revealed the temperature-dependent drug elimination; the clearance relative to bioavailability (CL/F) and elimination half-life at 30 °C (0.180 L/kg/h and 6.06 h, respectively) were about twice those at 25 °C (0.090 L/kg/h and 10.49 h, respectively). The optimal dosages at the minimum inhibitory concentration (MIC) of 2 μg/mL were 10.97 (25 °C) and 41.03 (30 °C) mg/kg/day, respectively. Finally, following the multiple oral administration, the muscle/skin residue of AMX on day 1 after the last dosing at 25 and 30 °C were 548 and 264 ng/g, respectively. The average tissue residues were depleted below the maximum residue limits (MRL) of 50 μg/kg on day 5 (25 °C) and 3 (30 °C), respectively, and the WDT were 6 and 4 days when rearing at 25 and 30 °C, respectively. This knowledge serves as a practical guideline for responsible use of AMX in treating bacterial diseases in Nile tilapia aquaculture. Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia ( Oreochromis niloticus ) reared at 25 and 30 °C as well as to determine optimal dosages and drug withdrawal time (WDT). In the PK investigation, the fish received a single dose of 40 mg/kg AMX via oral gavage, and the optimal dosage was determined by the pharmacokinetic-pharmacodynamic approach. In the tissue residue study, the fish were orally gavaged with 40 mg/kg/day AMX once daily for 5 days and the WDT was established by the linear regression analysis. The results revealed the temperature-dependent drug elimination; the clearance relative to bioavailability (CL/F) and elimination half-life at 30 °C (0.180 L/kg/h and 6.06 h, respectively) were about twice those at 25 °C (0.090 L/kg/h and 10.49 h, respectively). The optimal dosages at the minimum inhibitory concentration (MIC) of 2 μg/mL were 10.97 (25 °C) and 41.03 (30 °C) mg/kg/day, respectively. Finally, following the multiple oral administration, the muscle/skin residue of AMX on day 1 after the last dosing at 25 and 30 °C were 548 and 264 ng/g, respectively. The average tissue residues were depleted below the maximum residue limits (MRL) of 50 μg/kg on day 5 (25 °C) and 3 (30 °C), respectively, and the WDT were 6 and 4 days when rearing at 25 and 30 °C, respectively. This knowledge serves as a practical guideline for responsible use of AMX in treating bacterial diseases in Nile tilapia aquaculture. |
Author | Rairat, Tirawat Chou, Chi-Chung Ke, Hual-Jhong Ho, Wan-Cih Lu, Yi-Ping |
Author_xml | – sequence: 1 givenname: Tirawat surname: Rairat fullname: Rairat, Tirawat organization: Department of Fishery Biology, Kasetsart University – sequence: 2 givenname: Yi-Ping surname: Lu fullname: Lu, Yi-Ping organization: Biology Division, Veterinary Research Institute, Ministry of Agriculture – sequence: 3 givenname: Wan-Cih surname: Ho fullname: Ho, Wan-Cih organization: Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University – sequence: 4 givenname: Hual-Jhong surname: Ke fullname: Ke, Hual-Jhong organization: Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University – sequence: 5 givenname: Chi-Chung surname: Chou fullname: Chou, Chi-Chung organization: Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39192627$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kstuEzEUhi1URC_wCCBLbIpEgq8z4xWgiEulirKAtXXG40kcHDvYE0J3rJB4G56BR-FJ8DRpRVkgWbLk85_Pv4__Y3QQYrAIPaRkSklDnhFaSUbrasoIE1PGVSVrfgcd0aaWE6kEPUBHo2Yyig7Rcc5LQgSRorqHDrmiilWsPkLf3y8grcDETy7YwZn8FMf14FbgcRczzG3GEDq8dcOiS7Atx6VocewxrOJXZ5z3LuCy3jlvS83D2gE-vUg2mkWKK5dxcD4W8iY_wclCsh2GATN5xeXk97cfv37O7qO7PfhsH-z3E_Tx9asPs7eT84s3Z7OX5xMjKR0mtK-pssoKxdpWyFYxzgxTDREtFcAU6yUDVgEnxAAVQjDaNX1DJa-s5L3iJ-hsx-0iLPU6lYemSx3B6auDmOYaUjHrraaiTKnMSKpyX22gqZqWt0Qo2UoBRBbW8x1rvWlXtjM2DAn8LejtSnALPY9fNKW8IhWnhXC6J6T4eWPzoMu8jPUego2brDlRdSMZE6P08T_SZdykUGalORWkappajJYe_W3pxsv1fxeB3AlMijkn299IKNFjrvR1rvSYK73PVel7setzoY8lL9uYfKcHuPQx9QmCcaOP_yL-AG9y00k |
Cites_doi | 10.1016/j.aquaculture.2019.02.042 10.1111/j.1095-8649.1987.tb05276.x 10.1002/9781118675014.ch39 10.1111/j.1365-2885.2010.01231.x 10.4315/0362-028x-73.9.1664 10.1016/j.aquaculture.2019.734542 10.3390/pharmaceutics14040712 10.1111/are.13555 10.1046/j.1365-2656.1999.00337.x 10.1002/9781118675014.ch16 10.1046/j.1365-2109.2002.00783.x 10.1016/j.aqrep.2019.100184 10.1002/9781118675014.ch8 10.1111/jvp.12321 10.3390/ani13162568 10.1111/jfd.13137 10.1016/j.aquaculture.2019.734900 10.1016/j.aquaculture.2022.738719 10.1016/S0044-8486(02)00367-8 10.1577/H03-016 10.1016/j.cmpb.2010.01.007 10.1021/acs.est.2c09576 10.1021/es062437y 10.3390/pharmaceutics15041153 10.1111/jfd.13480 10.1111/jfd.13040 10.1016/0044-8486(92)90285-S 10.3109/00498254.2015.1089453 10.1111/j.1461-0248.2009.01415.x 10.1577/H04-033.1 10.1111/jvp.12773 10.1111/are.12764 10.1111/j.1365-2885.2004.00602.x 10.1016/0044-8486(90)90101-R 10.1016/S0044-8486(03)00452-6 10.1016/j.aquaculture.2018.12.081 10.1080/02772240903109092 10.1007/s10499-006-9047-0 10.1111/jwas.12131 10.1080/19440049.2022.2155710 10.1142/S1682648515500055 10.1111/jfd.13719 |
ContentType | Journal Article |
Copyright | 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) |
Copyright_xml | – notice: 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 – notice: 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) |
DBID | 0YH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7XB 8FK 8G5 ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO GNUQQ GUQSH M2O MBDVC PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI Q9U 7X8 5PM DOA |
DOI | 10.1080/01652176.2024.2396573 |
DatabaseName | Taylor & Francis Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) ProQuest Central (purchase pre-March 2016) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central ProQuest Central Student ProQuest Research Library Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Basic ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) Environmental Sciences and Pollution Management ProQuest Central ProQuest One Academic UKI Edition ProQuest Central Korea Bacteriology Abstracts (Microbiology B) ProQuest Research Library ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 0YH name: Taylor & Francis Open Access url: https://www.tandfonline.com sourceTypes: Publisher – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Veterinary Medicine |
DocumentTitleAlternate | T. Rairat et al |
EISSN | 1875-5941 |
EndPage | 9 |
ExternalDocumentID | oai_doaj_org_article_14391627599e47ca868b3b0495b54a05 PMC11360631 39192627 10_1080_01652176_2024_2396573 2396573 |
Genre | Research Article Journal Article |
GrantInformation_xml | – fundername: Animal and Plant Health Inspection Agency, Ministry of Agriculture, Executive Yuan, Taiwan grantid: 110AS-6.4.1-BQ-B1 |
GroupedDBID | --- .7F .QJ 0YH 123 4.4 53G 8G5 AAENE AAHBH ABCCY ABFIM ABUWG ACGFS ADBBV ADCVX AENEX AFKRA AGMYJ ALMA_UNASSIGNED_HOLDINGS AVBZW AZQEC BCNDV BENPR CCPQU CE4 DGEBU DWQXO EBS ECGQY EYRJQ E~A E~B F5P GNUQQ GROUPED_DOAJ GTTXZ GUQSH H13 HF~ HYE HZ~ H~P IPNFZ J.P M2O M4Z NA5 O9- OK1 PIMPY PROAC RIG RPM S-T TDBHL TEI TFL TFW UT5 UU3 ~KM ~S~ AAYXX CITATION NX0 PHGZM PHGZT 07X AAOAP APNXG AURDB BFWEY BPHCQ C0. CGR CUY CVF CWRZV DLOXE ECM EIF EJD HGUVV JEPSP L84 NPM NUSFT OWHGL PCLFJ PQQKQ TTHFI UB7 3V. 7QL 7XB 8FK C1K MBDVC PKEHL PQEST PQUKI Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c511t-1f719e9e492bb45b9232c29804b14a292f52a26a300ca144421d8f81536e53f93 |
IEDL.DBID | 0YH |
ISSN | 0165-2176 1875-5941 |
IngestDate | Wed Aug 27 01:10:42 EDT 2025 Thu Aug 21 18:32:02 EDT 2025 Thu Jul 10 18:54:55 EDT 2025 Mon Jun 30 13:53:14 EDT 2025 Thu Jan 02 22:38:39 EST 2025 Tue Jul 01 03:34:17 EDT 2025 Wed Dec 25 09:04:05 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | aquaculture withdrawal period tissue residue Antimicrobials penicillins fish |
Language | English |
License | open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c511t-1f719e9e492bb45b9232c29804b14a292f52a26a300ca144421d8f81536e53f93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.tandfonline.com/doi/abs/10.1080/01652176.2024.2396573 |
PMID | 39192627 |
PQID | 3140688745 |
PQPubID | 3933323 |
PageCount | 9 |
ParticipantIDs | informaworld_taylorfrancis_310_1080_01652176_2024_2396573 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11360631 proquest_journals_3140688745 doaj_primary_oai_doaj_org_article_14391627599e47ca868b3b0495b54a05 proquest_miscellaneous_3097852241 crossref_primary_10_1080_01652176_2024_2396573 pubmed_primary_39192627 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-Dec |
PublicationDateYYYYMMDD | 2024-12-01 |
PublicationDate_xml | – month: 12 year: 2024 text: 2024-Dec |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: The Hague |
PublicationTitle | The Veterinary quarterly |
PublicationTitleAlternate | Vet Q |
PublicationYear | 2024 |
Publisher | Taylor & Francis Taylor & Francis Ltd Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Ltd – name: Taylor & Francis Group |
References | AphA (e_1_3_4_3_1) 2014 Kumphaphat S (e_1_3_4_24_1) 2022 e_1_3_4_9_1 e_1_3_4_42_1 e_1_3_4_7_1 e_1_3_4_40_1 e_1_3_4_5_1 e_1_3_4_23_1 e_1_3_4_46_1 e_1_3_4_21_1 e_1_3_4_44_1 e_1_3_4_27_1 e_1_3_4_25_1 e_1_3_4_48_1 e_1_3_4_29_1 e_1_3_4_53_1 e_1_3_4_30_1 e_1_3_4_51_1 e_1_3_4_13_1 e_1_3_4_34_1 e_1_3_4_55_1 e_1_3_4_11_1 e_1_3_4_32_1 AVMA (e_1_3_4_4_1) 2020 e_1_3_4_38_1 Trevor AJ (e_1_3_4_49_1) 2015 e_1_3_4_36_1 EC (e_1_3_4_15_1) 2023 FAO (e_1_3_4_17_1) 2021 Gilbert DN (e_1_3_4_19_1) 2022 e_1_3_4_2_1 e_1_3_4_8_1 e_1_3_4_20_1 e_1_3_4_41_1 e_1_3_4_6_1 e_1_3_4_45_1 e_1_3_4_22_1 e_1_3_4_43_1 e_1_3_4_26_1 e_1_3_4_47_1 Lin M (e_1_3_4_28_1) 2015; 7 e_1_3_4_31_1 e_1_3_4_52_1 e_1_3_4_50_1 e_1_3_4_12_1 e_1_3_4_35_1 e_1_3_4_10_1 e_1_3_4_33_1 e_1_3_4_54_1 e_1_3_4_16_1 FAO (e_1_3_4_18_1) 2022 e_1_3_4_39_1 e_1_3_4_14_1 e_1_3_4_37_1 e_1_3_4_56_1 |
References_xml | – ident: e_1_3_4_34_1 doi: 10.1016/j.aquaculture.2019.02.042 – volume-title: The Sanford guide to antimicrobial therapy 2022 year: 2022 ident: e_1_3_4_19_1 – ident: e_1_3_4_5_1 doi: 10.1111/j.1095-8649.1987.tb05276.x – ident: e_1_3_4_43_1 doi: 10.1002/9781118675014.ch39 – ident: e_1_3_4_26_1 doi: 10.1111/j.1365-2885.2010.01231.x – ident: e_1_3_4_45_1 doi: 10.4315/0362-028x-73.9.1664 – ident: e_1_3_4_55_1 doi: 10.1016/j.aquaculture.2019.734542 – ident: e_1_3_4_53_1 doi: 10.3390/pharmaceutics14040712 – volume-title: The context of tilapia value chain development in Thailand. Bangkok: Food and agriculture organization of the United Nations year: 2021 ident: e_1_3_4_17_1 – ident: e_1_3_4_33_1 doi: 10.1111/are.13555 – ident: e_1_3_4_9_1 doi: 10.1046/j.1365-2656.1999.00337.x – ident: e_1_3_4_14_1 doi: 10.1002/9781118675014.ch16 – ident: e_1_3_4_44_1 doi: 10.1046/j.1365-2109.2002.00783.x – ident: e_1_3_4_21_1 doi: 10.1016/j.aqrep.2019.100184 – ident: e_1_3_4_35_1 doi: 10.1002/9781118675014.ch8 – ident: e_1_3_4_51_1 – ident: e_1_3_4_27_1 doi: 10.1111/jvp.12321 – ident: e_1_3_4_54_1 doi: 10.3390/ani13162568 – ident: e_1_3_4_31_1 doi: 10.1111/jfd.13137 – ident: e_1_3_4_42_1 doi: 10.1016/j.aquaculture.2019.734900 – ident: e_1_3_4_36_1 doi: 10.1016/j.aquaculture.2022.738719 – ident: e_1_3_4_50_1 doi: 10.1016/S0044-8486(02)00367-8 – ident: e_1_3_4_12_1 doi: 10.1577/H03-016 – ident: e_1_3_4_47_1 – volume-title: Commission regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, 02010R0037-20230611 year: 2023 ident: e_1_3_4_15_1 – ident: e_1_3_4_56_1 doi: 10.1016/j.cmpb.2010.01.007 – ident: e_1_3_4_16_1 – ident: e_1_3_4_30_1 doi: 10.1021/acs.est.2c09576 – ident: e_1_3_4_10_1 – ident: e_1_3_4_8_1 doi: 10.1021/es062437y – ident: e_1_3_4_25_1 doi: 10.3390/pharmaceutics15041153 – ident: e_1_3_4_37_1 doi: 10.1111/jfd.13480 – ident: e_1_3_4_38_1 doi: 10.1111/jfd.13040 – ident: e_1_3_4_7_1 doi: 10.1016/0044-8486(92)90285-S – ident: e_1_3_4_32_1 doi: 10.3109/00498254.2015.1089453 – volume-title: AVMA guidelines for the euthanasia of animals: 2020 edition year: 2020 ident: e_1_3_4_4_1 – ident: e_1_3_4_23_1 doi: 10.1111/j.1461-0248.2009.01415.x – ident: e_1_3_4_11_1 doi: 10.1577/H04-033.1 – ident: e_1_3_4_20_1 doi: 10.1111/jvp.12773 – volume-title: Drug information handbook with international trade names index year: 2014 ident: e_1_3_4_3_1 – ident: e_1_3_4_29_1 doi: 10.1111/are.12764 – ident: e_1_3_4_48_1 doi: 10.1111/j.1365-2885.2004.00602.x – start-page: 396 volume-title: Proceedings of the 60th Kasetsart University Annual Conference: Agricultural Sciences year: 2022 ident: e_1_3_4_24_1 – volume-title: Katzung & Trevor’s pharmacology: examination & board review year: 2015 ident: e_1_3_4_49_1 – ident: e_1_3_4_6_1 doi: 10.1016/0044-8486(90)90101-R – ident: e_1_3_4_13_1 doi: 10.1016/S0044-8486(03)00452-6 – ident: e_1_3_4_39_1 doi: 10.1016/j.aquaculture.2018.12.081 – volume-title: The State of World Fisheries and Aquaculture 2022. Rome: Food and Agriculture Organization of the United Nations year: 2022 ident: e_1_3_4_18_1 – ident: e_1_3_4_2_1 doi: 10.1080/02772240903109092 – volume: 7 start-page: 126 issue: 2 year: 2015 ident: e_1_3_4_28_1 article-title: Comparative pharmacokinetics of florfenicol in Japanese eels at different temperature publication-title: Anim Husb Feed Sci – ident: e_1_3_4_46_1 doi: 10.1007/s10499-006-9047-0 – ident: e_1_3_4_22_1 doi: 10.1111/jwas.12131 – ident: e_1_3_4_40_1 doi: 10.1080/19440049.2022.2155710 – ident: e_1_3_4_52_1 doi: 10.1142/S1682648515500055 – ident: e_1_3_4_41_1 doi: 10.1111/jfd.13719 |
SSID | ssj0040546 |
Score | 2.3632 |
Snippet | Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to... |
SourceID | doaj pubmedcentral proquest pubmed crossref informaworld |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1 |
SubjectTerms | Amoxicillin Amoxicillin - administration & dosage Amoxicillin - pharmacokinetics Animals Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - pharmacokinetics Antimicrobials Aquaculture Bacterial diseases Bioavailability Cichlids Dosage Dose-Response Relationship, Drug Drug dosages Drug Residues Drug withdrawal Fish Half-Life Microbial Sensitivity Tests Minimum inhibitory concentration Oral administration Oreochromis niloticus penicillins Pharmacodynamics Pharmacokinetics Regression analysis Residues Temperature Temperature dependence Tilapia tissue residue withdrawal period |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtUwELVQV2wQlFegICOxAImUG78SL6GiqpBaWFDUXTSObbWCJihNRZddIfE3fAOfwpcwEydX91ZI3SBlE78Ue8b2sTNzhrHnLmjbaGXyUHjIlfY6BxNC3viIVYx2PtB9x_6B2TtU74_00UqoL7IJS_TAaeBeF6NrqCi1tUGVDVSmctIhrtVOK0jspbjnzYeptAYjCkkuOgXZcBWlmX13iFUb0ygJz4ZCbQtpjS7l2q40kvdfoS79FwC9ake5sjHt3ma3JkTJ36Se3GE3QrvJNj-Tmcvoa8v3p9_nd9mPjxNR9Rd8JX7mV7zDJeMUq_uOLMzOOLSe092s7-E7JlPoed5FDqfdBTZCBN4cnwNcSzCPPOGAv_jQh6457jtUGd6efO2Iz-PsJe-JHtdzGLjQY7ty8efy5-9fO_fY4e67Tzt7-RSIIW8Qjw15EcvCBhx_K5xT2iEoFI2w1UK5QoGwImoBwoBcLBrAE5oSha9ihYupCVpGK--zjbZrw0PGQVQQjYuVKRslobHBB8BTMmDz0UjI2PYsiPpb4tuoi5nGdJJcTZKrJ8ll7C2Ja1mY6LLHBFSielKi-jolyphdFXY9jLclMYU2qeU1H7A1a0Y9zX-qoiiaT6mw6WfLbBQD_Y6BNnTnWIZcaDRBqIw9SIq07AV-LhE5lhmr1lRsrZvrOe3J8cgOTkF6EHcWj_7HwDxmN6mvyX5ni20M_Xl4gihscE_HCfcXp_Mrgg priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NbtQwELZge-GCoPwFCjISB5BI2fgv9gnRqlWF1KVCFPUW2bFDK2hcslvBkRMSb8Mz8Cg8CTOJs-pWCKRc4j_ZmslkZjzzDSFPXJCmlkLlofA2F9LL3KoQ8to3MEVJ5wP6O_Znau9QvD6SR8nhNk9hlaNM7AW1jzX6yF9wsASURnD2l2efc6wahberqYTGVbIGIljrCVnb2pkdvB1lMWgjQ6pOgbFcRanGHB5E14Y2bAIbkYlNxo2SJV_5O_Ug_pcgTP-miF6Op7zwg9q9Qa4nzZK-GljhJrkS2nWy_h7DXfqcW7qfrtFvke8HCbD6I7wiTvNzGkF0nMJ0HzHSbE5t6yn6aH1nv0AzlqCnsaH2NH6FRRDIm8IzA5kCfZgRZ-nTN12I9XEXgXVoe_IpIq7H_BntECbXU7ugTPbr8unvbz9-_dy-TQ53d95t7-WpIENeg162yIumLEwwQRjmnJAOlENWM6OnwhXCMsMaySxTlk-ntQVLTbDC60aDUFVB8sbwO2TSxjbcI9QybRvlGq3KWnBbm-CDBWvZwvKN4jYjmyMhqrMBd6MqRjjTRLkKKVclymVkC8m1HIyw2X1D7D5U6SsEOwfzjFkpDRyirK1W2nEHRpJ0UtipzIi5SOxq0XtNmqHEScX_s4GNkTOqJAdwysi1GXm87AYy4LWMbUM8hzGYSiNRlcrI3YGRlqeA7SKgY5kRvcJiK8dc7WlPjnuUcCzWA_pncf_f-3pAruEphgidDTJZdOfhIehZC_cofUx_AGqAJiQ priority: 102 providerName: ProQuest |
Title | Pharmacokinetics, optimal dosages and withdrawal time of amoxicillin in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C |
URI | https://www.tandfonline.com/doi/abs/10.1080/01652176.2024.2396573 https://www.ncbi.nlm.nih.gov/pubmed/39192627 https://www.proquest.com/docview/3140688745 https://www.proquest.com/docview/3097852241 https://pubmed.ncbi.nlm.nih.gov/PMC11360631 https://doaj.org/article/14391627599e47ca868b3b0495b54a05 |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELagvXBBUP4CZWUkDiCRkji2Ex9p1WqF1KVCFMEpGid2W0FjlN2qPXJC4m14Bh6FJ2EmP6tuBeKAlEvieGRnxuMZZ-Ybxp5ap0ylpI5dWkMsVa1i0M7FVe2xi1a2dnTesT_T00P5-oMaownnQ1gl-dC-B4rodDUtbrDzMSLuJWXgoCVNAQZCbonMaJVn19k67sQJFTFIPk5HZYzmSJ-rk1IwF_YZk3j-RmZle-pQ_K9gmP7JEr0aUHlph9q7xW4OpiV_1cvCbXbNNRts4z3Fu3RJt3x_-I9-h307GBCrP-EtATW_4AF1xyl2rwOFms05fh1Oh7R1C-f4mGrQ8-A5nIYLJEJI3hyvGSoVbKOUOODP3rQuVMdtQNnhzcnnQMAe8-e8JZzcmsOCC9XRzZJfX7___LFzlx3u7b7bmcZDRYa4QsNsEac-T40zThphrVQWrUNRCVMk0qYShBFeCRAasiSpAF01KdK68AVqVe1U5k12j601oXEPGAdRgNfWFzqvZAaVcbUDdJcByXudQcS2RkaUX3rgjTId8UwHzpXEuXLgXMS2iV3Llwk3u3sQ2qNyWIbo6FCisciVwUnkFRS6sJlFL0lZJSFRETOXmV0uumMT39c4KbN_DGBzlIxyUATURVJZn1wi6SfLZmQD_ZeBxoUzfIdyaRTZUhG73wvSchY4XEJ0zCNWrIjYyjRXW5qT4w4mnKr1oAGaPvyPOT1iN-i2j9_ZZGuL9sw9RitsYSfdOpuw9e3d2cHbSXeW8RuAQiye |
linkProvider | Taylor & Francis |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaq9gAXBOUVKGAkkEAiJfEryQEhWlptaXepUIt6C3bs0Aoal-xWhRsnJP4M4jfwU_glzOSx6lYITpVyiV-yNePxjD3zDSEPjJNZIYUKXWx1KKSVoVbOhYUtoYuSxjq87xiO1GBXvNqTe3PkRx8Lg26VvUxsBLX1Bd6RP-VgCagUwdmfH30KMWsUvq72KTRatth0X07AZBs_23gJ9H3I2Prazuog7LIKhAUoF5MwLpM4c5kTGTNGSAMaDitYlkbCxEKzjJWSaaY0j6JCg7khWGzTMgXJoJzkJYIvgchfEFxFbJ4srKyNtt_0sh-0nzY0KEbfsThRfcwQonlDGRaBTcrEMuOZkgmfOQ2bpAFnIFP_pvie9d88dSCuXyaXOk2WvmhZ7wqZc9UiWXyL7jVNjC8dds_2V8m37Q4g-wP8Ii70E-pBVB1Cd-vRs21MdWUp3gnbWp9AMaa8p76k-tB_hkEQOJzCNwIZBnUYgafpo9e188V-7YFVaXXw0SOOyPgxrRGW11I9oUw24_Lo99fvv36uXiO750Kq62S-8pW7SahmqS6VKVOVFILrInPWabDONQxfKq4DstwTIj9qcT7yuIdP7SiXI-XyjnIBWUFyTRsjTHdT4Ov3ebfrwa7CuGaWyAwWkRQ6VanhBowyaaTQkQxIdprY-aS5pSnblCo5_88ElnrOyDu5g136XRKQ-9NqIAM-A-nK-WNog6E7ElW3gNxoGWm6CpguAkgmAUlnWGxmmbM11cF-g0qOyYFA341v_Xte98iFwc5wK9_aGG3eJhdxRa130BKZn9TH7g7oeBNzt9tYlLw77738BwfkYGk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagSIgLgvJaKGAkDiCRNvEr8REKq-XRpQeK4BTZsU0raFxlU8GRExL_ht_AT-GXMJPHqluBOCDlkjge2ZnxeMaZ-YaQ-9ZLXUmhEp85kwjpZGKU90nlAnRR0jqP5x07czXbEy_eyTGacDGEVaIPHXqgiE5X4-I-cmGMiNvCDBywpDHAgIlNxrWSOT9LzknYe7F6Q_p-NipjMEf6XJ0Mg7mgz5jE8zcyK9tTh-J_CsP0T5bo6YDKEzvU9BK5OJiW9HEvC5fJGV-vk_W3GO_SJd3SneE_-hXybXdArP4ItwjU_IhG0B2H0N1FDDVbUPg6FA9pXWM-w2OsQU9joOYwfgEiiORN4ZqDUoE2TIkz9MHrxsdqv4kgO7Q--BQR2GPxkDaIk-uoaSmTHV2e_vr6_eeP7atkb_rszfYsGSoyJBUYZm2ShTzTXnuhmbVCWrAOWcV0kQqbCcM0C5IZpgxP08qAqyZY5opQgFZVXvKg-TWyVsfa3yDUsMIEZUOh8kpwU2nvvAF32QD5oLiZkM2REeVRD7xRZiOe6cC5EjlXDpybkCfIruXLiJvdPYjNh3JYhuDoYKIxy6WGSeSVKVRhuQUvSVopTConRJ9kdtl2xyahr3FS8n8MYGOUjHJQBNhFYFmfXADpe8tmYAP-lzG1j8fwDubSSLSlJuR6L0jLWcBwEdExn5BiRcRWprnaUh_sdzDhWK0HDNDs5n_M6S45v_t0Wr56Pn95i1zAlj6UZ4Ostc2xvw0GWWvvdEvuNz7ULKw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacokinetics%2C+optimal+dosages+and+withdrawal+time+of+amoxicillin+in+Nile+tilapia+%28+Oreochromis+niloticus+%29+reared+at+25+and+30%E2%80%89%C2%B0C&rft.jtitle=The+Veterinary+quarterly&rft.au=Rairat%2C+Tirawat&rft.au=Lu%2C+Yi-Ping&rft.au=Ho%2C+Wan-Cih&rft.au=Ke%2C+Hual-Jhong&rft.date=2024-12-01&rft.issn=0165-2176&rft.eissn=1875-5941&rft.volume=44&rft.issue=1&rft.spage=1&rft.epage=9&rft_id=info:doi/10.1080%2F01652176.2024.2396573&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_01652176_2024_2396573 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0165-2176&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0165-2176&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0165-2176&client=summon |